Down Syndrome, Obesity, Alzheimer's Disease, and Cancer: A Brief Review and Hypothesis
- PMID: 29587359
- PMCID: PMC5924389
- DOI: 10.3390/brainsci8040053
Down Syndrome, Obesity, Alzheimer's Disease, and Cancer: A Brief Review and Hypothesis
Abstract
Down syndrome (trisomy 21), a complex mix of physical, mental, and biochemical issues, includes an increased risk of Alzheimer's disease and childhood leukemia, a decreased risk of other tumors, and a high frequency of overweight/obesity. Certain features related to the third copy of chromosome 21 (which carries the APP gene and several anti-angiogenesis genes) create an environment favorable for Alzheimer's disease and unfavorable for cancer. This environment may be enhanced by two bioactive compounds from fat cells, leptin, and adiponectin. This paper outlines these fat-related disease mechanisms and suggests new avenues of research to reduce disease risk in Down syndrome.
Keywords: Alzheimer’s disease; adiponectin; cancer; down syndrome; leptin; obesity.
Conflict of interest statement
The author declares no conflicts of interest.
References
-
- Havercamp S.M., Tasse M.J., Navas P., Benson B.A., Allain D., Manickam K. Exploring the weight and health status of adults with Down syndrome. J. Educ. Train. Stud. 2017;5:97–108. doi: 10.11114/jets.v5i6.2343. - DOI
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
